ZTS:NYSE
Zoetis
80,04 US$
arrow_upward
+0,57%(+0,45) 1 d
80,04 US$
0,00% (0,00)
bedtimeFuera de horario
Cerrado: 20 oct, 16:00:04 GMT-4 · USD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de ZTS...
Abrir
79,64 US$
Alto
80,25 US$
Bajo
79,03 US$
Cap. burs.
33,07 mil M
Vol. medio
4,51 M
Volumen
3,74 M
Dividendo
2,65 %
Dividendo trimestral
0,53 US$
Fecha exdividendo
20 jul 2026
Ratio PER
13,17
Máximo en 52 sem.
148,30 US$
Mínimo en 52 sem.
68,77 US$
BPA
6,08 US$
Beta
0,74
Acciones en circulación
413,22 M
N.º de empleados
14 mil
Abrir
79,64 US$
Alto
80,25 US$
Bajo
79,03 US$
Cap. burs.
33,07 mil M
Vol. medio
4,51 M
Volumen
3,74 M
Dividendo
2,65 %
Dividendo trimestral
0,53 US$
Fecha exdividendo
20 jul 2026
Ratio PER
13,17
Máximo en 52 sem.
148,30 US$
Mínimo en 52 sem.
68,77 US$
BPA
6,08 US$
Beta
0,74
Acciones en circulación
413,22 M
N.º de empleados
14 mil
Noticias
De fuentes web y partners de noticias
GuruFocus
·
hace 9 horas
Zoetis (ZTS) Gains FDA Approval for Convenia RTU for Dogs, Enhan
Seeking Alpha
·
hace 9 horas
Zoetis: Weakening Fundamentals Overshadow The Discount (NYSE:ZTS)
Investing.com Canada
·
hace 10 horas
FDA approves Zoetis’ Convenia RTU for canine skin infections By Investing.com
Perfil
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
Acerca de Zoetis
CEOKristin C. Peck
Empleados14,5 mil
Fundación1952
SedeParsippany-Troy Hills, Nueva Jersey, Estados Unidos
Sector-
Sitio webzoetis.com